公司资料
Ambrx Biopharma 股价、新闻与催化剂
- 股票代码:
- AMAM
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for AMAM.
公司概览
业务概览
Ambrx Biopharma was an antibody-drug conjugate company focused on precision oncology before being acquired by Johnson & Johnson. Its platform centered on engineered biologics and targeted payload delivery.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before acquisition, Ambrx sat in oncology biotechnology.
商业模式特征
The business relied on ADC development, clinical data, and the strategic value of its biologic engineering platform.
生物医药行业定位
Ambrx was a differentiated ADC name and now belongs to biotech M&A history.
未来催化剂
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。